AMENDMENT NO. 7 TO AGREEMENTAgreement • November 2nd, 2021 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances
THIS AMENDMENT NO.7 TO AGREEMENT (this “Amendment”) is made effective as of July 9, 2019, between IDEXX Operations, Inc., a Delaware corporation whose principal place of business is at 6100 east Shelby Drive, Memphis Tennessee 38141, U.S.A. (“IDEXX”) and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (“OCD”).
AMENDMENT NO.5 TO AGREEMENTAgreement • November 2nd, 2021 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances
THIS AMENDMENT NO.5 TO AGREEMENT (this “Amendment”) is made effective as of July 9, 2019, between IDEXX Europe B.V., a corporation organized under the law of The Netherlands (“IDEXX”) and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (“OCD”).
